chrisvoncsefalvay/vaers-outcomes huggingface dataset:
About 3 minutes after patient received vaccines  patient stated he felt dizzy. He immediately closed his eyes and passed out. Patient stated he was just closing his eyes but was non responsive for about one minute. About 5 minutes later patient vomited and stated he felt much better. Patient was sweating. He was given apple juice, water and offered cookies. Patients vitals were taken as well as blood sugar levels. Vitals and Blood glucose were within normal limits.
Pt has been hospitalized with new onset DKA on 6/20/21.  Mom describes onset of fatigue and malaise following the 2nd vaccine given on 6/16/2021.
Immediately, post vax, pt felt throat and neck swelling with some labored breathing and also had panic attack. Pt reported the adverse reaction on visit of 10/23/00. She, at the time, still complained of left side of neck swelling. She was give Benadryl. Pt states, at this time, an allergy to eggs, not earlier reported. MMR consent signed by pt.
FELT ITCHY FOR A FEW DAYS; RASH; WELT/HIVES; This spontaneous report received from a patient concerned a 53 year old male. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805018, and expiry: 23-AUG-2021) dose was not reported, administered on 05-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 12-MAR-2021, the patient experienced felt itchy for a few days. On 12-MAR-2021, the patient experienced rash. On 12-MAR-2021, the patient experienced welt/hives. Treatment medications (dates unspecified) included: hydrocortisone, and diphenhydramine hydrochloride. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from felt itchy for a few days on 19-MAR-2021, and rash on 12-MAR-2021, and the outcome of welt/hives was not reported. This report was non-serious.
Pre-drawn syringes that were withdrawn and left out at room temperature for over 12 hours. At least one to three of the doses were administered to patients; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Pre-drawn syringes that were withdrawn and left out at room temperature for over 12 hours. At least one to three of the doses were administered to patients) in an 18-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 051C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Jun-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Pre-drawn syringes that were withdrawn and left out at room temperature for over 12 hours. At least one to three of the doses were administered to patients). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Pre-drawn syringes that were withdrawn and left out at room temperature for over 12 hours. At least one to three of the doses were administered to patients) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was provided. No treatment medication information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 07-Jul-2021: Follow up information received on 07-JUL-2021 contains no new information.
From the PNEUMOVAX 23 Injection: Severe headache and neck pain with right arm weakness, tingling, swelling, severe arm pain and inability to move the right arm for at least 2 days. Progressed to redness over the entire right upper arm front and back of the arm and on the 4th day it appeared as a splotchy rash that felt like a sunburn. Also 4th day bruising appeared on upper mid arm in the front and redness spread as far as the elbow on the back of the arm. There was nausea for two days. There was no redness at the exact injection site.
Pt states after getting the VARIVAX #2 and BOOSTRIX her LEFT arm had severe swelling. Pt states the swelling has decreased and has not effected her way of life.
This case was reported by a pharmacist via call center representative and described the occurrence of injection site swelling in a 73-year-old female patient who received SHINGRIX (batch number DD43M, expiry date unknown) for prophylaxis. On 6th September 2018, the patient received the 1st dose of SHINGRIX. On an unknown date, less than 2 weeks after receiving SHINGRIX, the patient experienced injection site swelling, injection site erythema, injection site pain and injection site induration. On an unknown date, the outcome of the injection site swelling, injection site erythema, injection site pain and injection site induration were unknown. It was unknown if the reporter considered the injection site swelling, injection site erythema, injection site pain and injection site induration to be related to SHINGRIX. Additional details were provided as follows: The reporter had a consumer that received the SHINGRIX vaccination in left deltoid and had experienced a hard red area approximately 2 inches in diameter, arm pain, and swelling at the injection site.
fever to 103, lethargy, limpness, hives all started 6-8hr following tx DPH, advil;
Booster dose given at incorrect interval-given too soon.  Previous booster dose was 6/28/22
left side body numbness Narrative:  2-4 had fatigue 2-3 days then 2-10 6 days after vaccine developed left side of body numbness. Spoke with Dr about this
i swelled up after coming home from the vaccination place, constipation and tired and wasn't able to do anything nausea.
Anaphylaxis in 12 minutes. Epi 2 times, Benadryl IM, Decadron PO, Albuterol MDI 4 times.
Hemorrhagic purpura - developed 4-6 hrs after vaccine lasted 1 month - 2-3 developed nose bleed lasted 2 months swelling ankles lasted 2wks - wheezing developed 1-2 after vaccine - 3 weeks after vaccine when the swelling decreased had pain + numbness in left foot.
In the afternoon of the day my vaccine I experienced tenderness in my arm. By late afternoon I started feeling extreme muscle weakness in my whole body and had the chills. I took a hot bath to try to ease the pain and chill. After the bath I crawled into bed and experienced extreme fever, chills, and weakness through the night.   The next day I continued to suffer from extreme fatigue. Now it is evening of the day after the vaccine and I only feel a little weak.
During screening for the vaccine at a clinic, ct said she had 'too many allergies' to list. RN escorted client to the local hospital and gave her the COVID vaccine there so she could be monitored there. Two hours after client received vaccine when she was at home she became very itchy, was uncomfortable for 4 days, stated this happens to her all the time. Then was ok.  02/03/2021-ct reported PCP told her not to get the second dose of Moderna to wait until the Johnson/Johnson vaccine was available then get it since it will only be one dose.
PT RECEIVED 3 VACCINES ON 11/29/2022 FLUARIX ,PFIZER AND SHINGRIX . Patient came to the pharmacy on 01/11/2023 and complained about left arm/shoulder pain that started after getting the vaccines (she received Fluarix and Shingrix on left arm) and limited mobility of her arm. Pt reported using a medrol dose pack that helped her with pain. The patient also stated that she submitted VAERS on her own. 08102023 patients again came to the pharmacy and reported continuing side effects of shoulder and arm pain. She has been to different providers and  received cortisone shots that helped her for a bit but the pain is back. Her MRI was denied by insurance. Her doctor also suspects frozen shoulders.  Patient might pay out
Fever 102 degrees; Severe headaches; Body muscle pain; Facial swelling; "Lymph neck swelling in extremities"; This is a spontaneous report from a contactable consumer, the patient. A 56-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ew0150) via an unspecified route of administration in the left arm on 07Apr2021 at 14:15 (at the age of 56-years-old) as a single dose for COVID-19 immunisation. Medical history included sjogren's autoimmune disorder and COVID-19. Concomitant medications included duloxetine hydrochloride (CYMBALTA), vitamin a nos (MANUFACTURER UNKNOWN), vitamin d nos (MANUFACTURER UNKNOWN) and multivitamins; all for unknown indication from an unknown date. The patient previously took codein, valium and versed and experienced drug allergy. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Apr2021 at 22:00, the patient experienced fever 102 degrees, severe headaches, body muscle pain, facial swelling and lymph neck swelling in extremities. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of adverse events and included treatment with OTC fever, pain relievers and Flexeril for muscle. On 07Apr2021, the patient underwent lab test and procedure which included body temperature and the result was 102 degrees. The clinical outcome of the event fever 102 degrees, severe headaches, body muscle pain, facial swelling and "lymph neck swelling in extremities" was resolved with sequelae in 4 days (stop date:11Apr2021).  No follow-up attempts are needed. No further information is expected.
Localized erythema, swelling, itching approximately 2 cm area at vaccination site to left deltoid.
Site: Bruising at Injection Site-Mild, Site: Itching at Injection Site-Mild, Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Mild
This spontaneous report as received from a registered nurse refers to an unspecified number of patients of unknown age and gender. There was no information about the patients' concurrent conditions, concomitant therapies or medical histories provided. On unknown dates the patients were vaccinated with improperly stored dose of GARDASIL 9 lot # L024993 with expiration date 17-OCT-2017, lot # L045700 with expiration date: 22-FEB-2018 (dose, dose number and route of administration were not reported). There was no adverse effect reported. Administered doses of vaccines experienced the temperature excursion of 52.8 degrees Fahrenheit for 1 hour and 15 minutes. Data logger was not involved. This is one of several reports received from the same reporter. Additional information has been requested.
First 24 hours nothing but pain at injection site. Second day nausea, joint pain, muscle weakness and headaches.
"Flu-like illness", macular/papular lesions on chest, back and upper arms. One lesion on roof of mouth.
A red rash going down from the sight of injection. Started sometime on the 27th and she called pharmacy on the 28th. Patient said rash was hot and sore but getting better.
Patient reports that she received her booster dose of the Moderna COVID-19 vaccine 12/29/2021. Per patient, she started to not feel well on 12/30/2021. Patient reports myalgias, fatigue, headaches, sinus pressure, nasal congestion, post nasal drainage and fevers. Per patient, temperature at highest was on 12/30/2021 at 103.5.
GENERALIZED BURNING PAIN TO BILATERAL ARAMS AND LEGS, UNABLE TO LIFT ARMS AND LEGS. FEVER OF 103, HEADACHE COUGHING, UNABLE TO WALK SYMPTOMS OCCURRED ON 06/08/2021, BURNING PAIN AND HEAXHE BECAME SEVRE CALL MD AND WAS ADVISED TO EMERGENCY ROOM FOR FURTHER EVALUATION OF ACUTE SYMPTOMS. I WAS admitted TO THE HOSPITAL WITH PNEUMONIA, HIGH FEVER AND GENERALIZED BODY BURNING PAIN WITH SEVRE HEADACHE. STAYED IN THE HOSPITAL FOR 7 DAYS C-RP LEVELS, SED RATGE AND WBC WERE ELEVATED TREATMENT CONSISTENT OF HIGH DOSE IV SOLUMEDROL,IV INFUSION OF NORMAL SALINE, FOUR IV OF ANTIBIOTICS. DISCHARGED HOEME AFTER 7 DAYS IN THE HOSPITAL WENT HOME ON HIGH DOSES OF PREDNISONE AND GABAPENTIN.  COMPLETED TREATMENTS OF MEDICATIONS GIVEN. RE-HOSPITALIZED ON 07/31/2021 FOR GENERALIZED BURNING PAIN TO BILATERAL ARRMS AND LEGS UNABLE TO MOVE ARMS AND LEGS.
At about 2pm I started bleeding, went into the triage to be evaluated, they sent me home at about 545 PM and within an hr home my water broke. Went back to hosp, was admitted and was put on isolation precautions cause of risk of H1N1. My seasonal and influenza A swabs came back negative but because I was hospitalized they had to send the swabs out but they still kept me on precautions, I delivered a still born baby at 0650 on 11/5/09.  12/01/09 DOS 11/04/09 -  DX: Fetal death  15 week pregnant Pt c/o vaginal watery fluid, possible water breaking, and some vaginal bleeding.  On examination: Pt had fever. Fetus was still viable. Pt's physician considered the prognosis of pregnancy poor due to placental fluid loss and possible infection. Pt lost fetus later the next day.
pt recv vax 12JUL96 & 18JUL96 pt devel a classic full-blown case of chicken pos;19JUL96 pt presented to MD;MD assumed pt had an exposure to chickenpox prior to vax;seen by MD again 22JUL96 & was healing appropriately;
Client complain of head ached 20 minutes after vaccination. Client medicated self with ibuprofen from her personal supply.  Started feeling better and walked out 13:12pm. Hx of fever, body chills, nausea, diarrhea one hour after first vaccination.
Patient remained in clinic for 8 mins prior to departure with no adverse reaction noted or reported. Patient presented to ED 2/23 with headache, diffuse rash and muscle aches starting the day after receiving immunization during PCP appt. Patient also reports photophobia, stiff neck, nausea and vomiting. Patient was treated in ED with ceftriaxone and patient was admitted observation status for concerns of meningitis and sent home with kenalog cream for rash and ibuprofen for pain.   2/25-patient called by PCP's nursing staff. Patient reports she is feeling better but still has a headache. Rash is improved as well as neck stiffness. Patient did not want to schedule a follow up with PCP. Nursing staff will contact patient tomorrow to check in and encourage a follow up appt.
Immediately after injection patient felt dizzy and nauseous . Patient was sitting in chair in vaccination booth.  After about 3 to 4 minutes she said she felt like passing out so I (pharmacist) let her sit on floor (she also had a toddler under age of 2 with her that was crying)  Pharmacy staff brought cool wash cloth and water to offer patient .  She stayed in booth for 30 -40 minutes after lying on back on floor with feet raised on chair.  Her husband arrived and she started feeling better and walked to her car with husband and pharmacist.  I followed up with her in 2 hours and she was feeling much better.
Pruritus, burning, swelling of entire arm, hives on entire arm and sharp stabbing pain.
Information has been received from a 54 year old female physician (the current 57 year old) with type 2 diabetes mellitus and "MT" who on 21-MAY-2007 was vaccinated SQ in the left arm with the first dose of ZOSTAVAX (Merck) (lot# not reported). Concomitant therapy included BYETTA, ADALAT CC, CIPRO and FLAGYL and "Z-pach". The physician stated that on 30-MAR-2011 (also reported as 02-FEB-2011), she experienced herpes simplex virus around mouth and eyes. The physician also stated that she did not have herpes simplex virus (HSV) symptoms before vaccination. There was no illness at time of vaccination. At the time of the report, the physician's outcome was unknown. Additional information has been requested.
Sore nipples and armpits for several days then today light vaginal bleeding  I am in or done with menopause and have not had a period for several years
This spontaneous report as received from a patient's mother refers to a 12 month old male patient. The patient had no pertinent medical history and no drug reactions/allergies. On 15-JAN-2019 the patient was vaccinated with M-M-R II, 1 injection, lot # unknown, via unspecified route. Concomitant therapies were not reported. The mother said that on 20-JAN-2019, reported as 'on Sunday' the patient developed an unspecified fever that resolved on Monday (21-JAN-2019). On 29-JAN-2019 (reported as yesterday), a rash that did not itch developed on the patient's torso. The mother said the rash did not seem to bother the patient. However the mother said she noticed on 30-JAN-2019, the rash was spreading to the patient's face and near his eyes. She had not treated the rash and was waiting for a physician's consult. No lab diagnostics were done at the moment of report. The outcome of rash was reported as not recovered/not resolved. The causality assessment was not provided.
This spontaneous report as received from a other health professional refers to a unspecified number of patients of unknown age and gender. The patients' medical history and current conditions were not provided. On an unknown dates in approximately 2015 (reported as since 06-JUN-2015), the patients were vaccinated with a doses of VARIVAX (Merck) (strength, dose and frequency were not reported) lot # K016127 expiration date 23-SEP-2016 and lot # L007225, expiration date 03-MAR-2017 that were exposed to temperatures outside of the recommended range. No adverse experience was reported. This is one of several reports received from the same reporter. Additional information has been requested.
A non-serious spontaneous report of administration of expired FLUMIST was received from a health professional concerning a ten-year-old female. Neither the patient's past medical history nor the concomitant medications were reported. The product expired on 22-Nov-2010. The patient received the expired FLUMIST on 30-Nov-2010. There was no adverse event associated with this medication error; therefore, treatment and reporter causality assessments are not applicable, and the event was considered resolved. 07-Mar-2011: Follow up call was conducted on 07-Mar-2011, no adverse events were reported following administration of the expired FLUMIST.
Hurt at injection; big pale pink rectangular area with a red dot; big bright red spot; Shower stung; This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 86-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix with an associated reaction of injection site pain (1st dose received on April 2019 in left arm and experienced injection site tenderness, injection site coloration and nonspecific reaction, refer case US2019137560.).   On 26th July 2019, the patient received the 2nd dose of Shingrix. In July 2019, less than a week after receiving Shingrix, the patient experienced injection site pain, injection site coloration, injection site erythema and stinging skin. On an unknown date, the outcome of the injection site pain, injection site coloration, injection site erythema and stinging skin were unknown.   It was unknown if the reporter considered the injection site pain, injection site coloration, injection site erythema and stinging skin to be related to Shingrix.  Additional case details were reported as follows: The patient hurt at injection. The patient had the same reaction with a big pink rectangular area approximately 2-3 inches at the injection site that was pinkish and hurt to the touch with a red dot. The patient took a shower and the shower stung and she noticed there was now a big red spot that was bright red. The reporter gave permission to follow up. This case has been linked with US2019137560, reported by the same reporter for the same patient.
Developed Rash on bilat arms, small red scattered bumps. No difficulty breathing, or other symptoms.   VSS BP 126/88 HR93 (states he always has an elevated HR) O2 sat 100% at 15:05pm.  rapid response team called - assess pt - pt declined to go to ER, waited additional 20 minutes. VS at 1530 122/77 HR 91 O2 sat 100%
Raised red cirles around injection site that spread across chest, abdomen, neck and arms. Achy, tired, nausea, diarrhea.
fainting; This is a spontaneous report from a contactable consumer. This consumer reported for female consumer (nurse). A female patient of an unspecified age received bnt162b2 (COMIRNATY, Formulation: solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as DOSE NUMBER UNKNOWN, SINGLE for covid-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date, the patient experienced fainting in the hospital. Just a few minutes after receiving the vaccine she had this encounter. Event assessed as medically significant. The clinical outcome of the event was unknown.   Follow-up attempts are completed. No further information expected.
No additional AE reported; Nurse reported that PNEUMOVAX 23 was administered to a couple twice. This AE is for the wife. Please see AE case 02256651 for the husband. Patient received one dose of PNEUMOVAX 23 on 9/19/2022 and was accidently given a dose again of PNEUMOVAX 23 on; Information has been received from a nurse, referring to a 88 year-old female patient. The patient's medical history, concurrent conditions and concomitant therapies were not reported.  On 19-SEP-2022, the patient was vaccinated with a dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) (strength, lot number, expiration date and administration route was not provided) for prophylaxis. Later on 27-SEP-2022, the patient was accidently given an additional dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) 0,5 ml, lot # U027357 and expiration date 25-MAR-2023 (administration route was not provided) for prophylaxis. No additional adverse effects were reported.
This spontaneous report as received from a pharmacist refers to patients of under 50 years old. On an unknown date the patients were vaccinated with ZOSTAVAX (dose unknown and route) "off-label". Amount of patients that received ZOSTAVAX "off-label" was unknown. No adverse effect reported. Additional information has been requested.
death. Per son pt was not  feeling well after the vaccination "like her legs were weak." Son found the mom in her bed 1am on 2/12/2021 unresponsive.
Pt. experienced syncope with seizure like spasms shortly with receiving GARDASIL 9 - had second episode of syncope and seizure like spasm within 5-8 minutes of first.